CSF2 and Absence of circulating granulocytes: This downward trend may be attributed to improvements in intensive care treatments, the availability of effective broad-spectrum antibiotics, heightened physician vigilance regarding drug-induced agranulocytosis, prompt cessation of suspected drugs, and the proactive use of G-CSF or GM-CSF in patients with severe agranulocytosis (Andersohn et al., 2007).